HK1215192A1 - 用於加速骨生長的無定形碳酸鈣 - Google Patents

用於加速骨生長的無定形碳酸鈣

Info

Publication number
HK1215192A1
HK1215192A1 HK16103275.2A HK16103275A HK1215192A1 HK 1215192 A1 HK1215192 A1 HK 1215192A1 HK 16103275 A HK16103275 A HK 16103275A HK 1215192 A1 HK1215192 A1 HK 1215192A1
Authority
HK
Hong Kong
Prior art keywords
calcium carbonate
bone growth
amorphous calcium
accelerated bone
accelerated
Prior art date
Application number
HK16103275.2A
Other languages
English (en)
Inventor
歐爾文．梅倫
蓋利特．薛泰爾-高德
麥克．丹尼利
Original Assignee
Amorphical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorphical Ltd filed Critical Amorphical Ltd
Publication of HK1215192A1 publication Critical patent/HK1215192A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
HK16103275.2A 2013-02-11 2016-03-21 用於加速骨生長的無定形碳酸鈣 HK1215192A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361762981P 2013-02-11 2013-02-11
PCT/IL2014/050138 WO2014122658A1 (en) 2013-02-11 2014-02-10 Amorphous calcium carbonate for accelerated bone growth

Publications (1)

Publication Number Publication Date
HK1215192A1 true HK1215192A1 (zh) 2016-08-19

Family

ID=51299297

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16103275.2A HK1215192A1 (zh) 2013-02-11 2016-03-21 用於加速骨生長的無定形碳酸鈣

Country Status (10)

Country Link
US (1) US20150374747A1 (zh)
EP (1) EP2953632A4 (zh)
JP (1) JP2016507553A (zh)
CN (1) CN105007925A (zh)
AU (1) AU2014213643A1 (zh)
CA (1) CA2898178A1 (zh)
EA (1) EA201591152A1 (zh)
HK (1) HK1215192A1 (zh)
TW (1) TW201442715A (zh)
WO (1) WO2014122658A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2956050C (en) * 2014-07-31 2023-09-12 Amorphical Ltd. Non-aqueous liquid and semi-solid formulations of amorphous calcium carbonate
IL256064B2 (en) * 2015-06-04 2024-04-01 Amorphical Ltd Preparations of amorphous calcium carbonate for administration by inhalation, under the tongue or through the palate
US10342895B2 (en) * 2015-06-23 2019-07-09 Mbp (Mauritius) Ltd Pulverulent semisynthetic material obtained by modifying the composition of a natural marine biomaterial, method of manufacture thereof, and applications thereof
EP3367975A4 (en) * 2015-10-28 2019-08-07 Launchpad Medical, LLC COMPOSITIONS AND METHODS FOR THE REGENERATION OF BONE TISSUE
CN108778296B (zh) * 2016-01-18 2024-07-09 艾玛菲克有限公司 治疗神经、肌肉和不育疾病或状况的稳定的无定形碳酸钙
BR112018014519A2 (pt) * 2016-01-18 2018-12-11 Amorphical Ltd. carbonato de cálcio amorfo estabilizado como um suplemento para meios de cultura celular
SE540790C2 (en) * 2016-02-12 2018-11-13 Stora Enso Oyj Calcium carbonate precipitated on natural fibers and method for the production thereof
WO2018078616A1 (en) * 2016-10-25 2018-05-03 Amorphical Ltd Amorphous calcium carbonate for treating a leukemia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037639A (en) * 1989-05-24 1991-08-06 American Dental Association Health Foundation Methods and compositions for mineralizing calcified tissues
US7105182B2 (en) * 2001-07-25 2006-09-12 Szymaitis Dennis W Periodontal regeneration composition and method of using same
EP1758599B1 (en) * 2004-05-26 2013-11-27 Ben Gurion University Of The Negev Research And Development Authority Orally-administrable compositions comprising stable amorphous calcium carbonate
GB0522045D0 (en) * 2005-10-28 2005-12-07 Novartis Ag Pharmaceutical compositions
IL178495A (en) * 2006-10-05 2014-12-31 Univ Ben Gurion Use of cancerous gastric components or artificial calcium containing carbonate, chitin and polypeptide preparations to treat calcium metabolism-related or calcium-signaling conditions
WO2008128342A1 (en) * 2007-04-18 2008-10-30 Mcgill University Composition for enhancing bone formation
WO2009053967A1 (en) * 2007-10-22 2009-04-30 Amorphical Ltd. Stable amorphous calcium carbonate comprising phosphorylated amino acids, synthetic phosphorylated peptides, and gastrolith proteins
TR200900878A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
CA3056570C (en) * 2011-12-13 2022-04-19 Amir Sagi Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders

Also Published As

Publication number Publication date
EP2953632A1 (en) 2015-12-16
AU2014213643A1 (en) 2015-08-06
WO2014122658A1 (en) 2014-08-14
TW201442715A (zh) 2014-11-16
EP2953632A4 (en) 2016-09-21
CA2898178A1 (en) 2014-08-14
US20150374747A1 (en) 2015-12-31
JP2016507553A (ja) 2016-03-10
CN105007925A (zh) 2015-10-28
EA201591152A1 (ru) 2016-03-31

Similar Documents

Publication Publication Date Title
IL243599A0 (en) surgical implant
IL240398A0 (en) surgical implant
IL240349A0 (en) surgical implant
IL250205B (en) Preparations containing dissolved amorphous calcium carbonate
IL240534A0 (en) surgical implant
HK1220602A1 (zh) 可生物吸收的生物醫學植入物
HK1222313A1 (zh) 可生物吸收的生物醫學植入物
PL2840065T3 (pl) Sposób wytwarzania strącanego węglanu wapnia
HK1215192A1 (zh) 用於加速骨生長的無定形碳酸鈣
ZA201603812B (en) Bone filler implanting system
HK1219907A1 (zh) 來自非哺乳動物組織的脫細胞化的生物材料
EP2967552B8 (en) Tissue capturing bone anchor
EP3302505C0 (en) AMORPHOUS CALCIUM CARBONATE STABILIZED WITH POLYPHOSPHATES
HK1209095A1 (zh) 用於生產穩定的非晶形碳酸鈣的方法
PT2958603T (pt) Endurecimento melhorado de substituto ósseo endurecível
PL3062718T3 (pl) Implant do osteotomii
KR101391404B9 (ko) 골신장기
HK1223308A1 (zh) 可吸收的仿生韌帶假體
HK1220146A1 (zh) 用於骨質增大的丙烯酸粘固劑
GB201307817D0 (en) Bone Growth Scaffold
IL240120A0 (en) Amorphous calcium carbonate for accelerated bone growth
GB201302143D0 (en) Bone reponator
HUP1300549A2 (hu) Kalciumkarbonátot tartalmazó levéltrágya.
AU2013904028A0 (en) Bone formation
GB201312617D0 (en) Bone replacement prosthesis